GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
GRAIL (Nasdaq: GRAL) will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2, 2025 at 3:00 p.m. ET.
Company management's presentation will be available via live webcast and replay at investors.grail.com. The webcast will be archived and available for at least 30 days after the event.
GRAIL (Nasdaq: GRAL) parteciperà alla Piper Sandler 37.ª Conferenza Annuale sulla Salute il martedì 2 dicembre 2025 alle 15:00 ora ET.
La presentazione della direzione aziendale sarà disponibile tramite webcast in diretta e replay su investors.grail.com. Il webcast sarà archiviato e disponibile per almeno 30 giorni dopo l'evento.
GRAIL (Nasdaq: GRAL) presentará en la Piper Sandler 37.ª Conferencia Anual de Cuidado de la Salud el martes 2 de diciembre de 2025 a las 3:00 p.m. ET.
La presentación de la dirección de la empresa estará disponible vía webcast en vivo y en reproducción en investors.grail.com. El webcast estará archivado y disponible durante al menos 30 días después del evento.
GRAIL (Nasdaq: GRAL)는 Piper Sandler 37th Annual Healthcare Conference에서 2025년 12월 2일 화요일 오후 3:00(동부 표준시 ET) 발표합니다.
회사 경영진의 발표는 investors.grail.com에서 라이브 웹캐스트 및 다시 보기를 통해 이용 가능할 예정입니다. 웹캐스트는 이벤트 종료 후 최소 30일 동안 보관됩니다.
GRAIL (Nasdaq : GRAL) présentera lors de la Piper Sandler 37e conférence annuelle sur les soins de santé le mardi 2 décembre 2025 à 15h00, heure de l'Est (ET).
La présentation de la direction de l'entreprise sera disponible via webcast en direct et en replay sur investors.grail.com. Le webcast sera archivé et disponible pendant au moins 30 jours après l'événement.
GRAIL (Nasdaq: GRAL) wird am Dienstag, dem 2. Dezember 2025 um 15:00 Uhr ET an der Piper Sandler 37th Annual Healthcare Conference teilnehmen.
Die Präsentation des Unternehmensmanagements wird über Live-Webcast und Replay unter investors.grail.com verfügbar sein. Der Webcast wird archiviert und mindestens 30 Tage nach der Veranstaltung verfügbar sein.
GRAIL (ناسداك: GRAL) ستُقدِّم في مؤتمر Piper Sandler الصحي السنوي السابع والثلاثين في الثلاثاء 2 ديسمبر 2025 الساعة 3:00 مساءً بتوقيت شرق الولايات المتحدة ET.
سيكون عرض الإدارة متاحاً عبر البث المباشر والإعادة على investors.grail.com. سيُ archived وسيكون متاحاً لمدة لا تقل عن 30 يوماً بعد الحدث.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-piper-sandler-37th-annual-healthcare-conference-302618810.html
SOURCE GRAIL, Inc.